We came across a bullish thesis on iCAD, Inc. (ICAD) on Twitter by northeasternsvf. In this article, we will summarize the bulls’ thesis on ICAD. iCAD, Inc. (ICAD)’s share was trading at $2.83 as of Feb 20th.
A doctor consulting with a patient, discussing treatment options for breast cancer.
iCAD is a leading AI medical technology company focused on innovative cancer detection solutions. Headquartered in Nashua, N.H., the company provides AI-powered mammography analysis through its...
